Wednesday, October 28, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Multisystem Outcomes of GLP-1 Receptor Agonists Versus Active Comparators in Type 2 Diabetes: A Multicenter Target Trial Emulation

Journal of diabetes science and technology · 2026 Oct 28 · Vashisht R, Dhruva SS, Patel A et

MH
By Maren Holt · Senior Reporter, GLP-1

From the source

Multisystem Outcomes of GLP-1 Receptor Agonists Versus Active Comparators in Type 2 Diabetes: A Multicenter Target Trial Emulation

Journal of diabetes science and technology · 2026 Oct 28 · Vashisht R, Dhruva SS, Patel A et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →